Business Context and Reporting Period
Company: FitLife Brands, Inc. (formerly Bond Laboratories, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: September 27, 2013
Event: Completion of a planned recapitalization involving the redemption, conversion, and warrant exchange of Series C Convertible Preferred Stock.
Key Financial Metrics and Transaction Details
This filing details a specific capital restructuring event rather than periodic financial performance. Key transaction metrics include:
- Cash Outflow (Redemption): $670,084 paid to redeem one-half of outstanding Series C Preferred shares at $10,000 per share plus accrued dividends.
- Equity Issuance (Conversion): 2,680,337 shares of Common Stock issued upon conversion of remaining Series C Preferred shares and accrued dividends at a rate of $0.25 per share.
- Equity Issuance (Warrant Exchange): 624,998 shares of Common Stock issued in exchange for the cancellation of 2,500,000 warrants.
- Total New Shares Issued: 3,305,335 shares of Common Stock.
Note: The filing text does not provide clear values for revenue, profit, operating cash flow, margins, total debt, or liquidity ratios.
Material Changes Versus Prior Period
The filing reports the completion of a recapitalization plan originally disclosed on September 10, 2013. The primary material changes are:
- Reduction of Series C Convertible Preferred Stock obligations through partial cash redemption and full conversion of the remainder.
- Elimination of 2,500,000 outstanding warrants.
- Significant increase in the number of outstanding Common Stock shares due to the conversion and exchange.
Guidance, Outlook, and Risks
Management Commentary: The transaction marks the completion of the Company's planned recapitalization. The shares referenced in the report were issued prior to a one-for-ten reverse stock split consummated on September 30, 2013.
Regulatory Status: The issuance of 3,305,335 shares was conducted as unregistered sales of equity securities, exempt under Section 4(2) and/or 3(a)(9) of the Securities Act and Rule 506 of Regulation D. All holders represented they were "accredited investors."
Risks/Contingencies: The filing does not explicitly list new risks or contingencies beyond the execution of the agreement.
Investor Verification Checklist
- Verify the impact of the 3,305,335 newly issued shares on total share count and potential dilution, noting the subsequent one-for-ten reverse split.
- Confirm the cash impact of the $670,084 redemption payment on the Company's current liquidity position.
- Review the attached Exhibit 10.1 (Form of Exchange Agreement) for specific terms regarding accrued dividends and conversion mechanics.
- Check subsequent filings for the official post-split share count and updated capitalization table.